Investigational Site Number 1150 — New York, New York

Investigational Site Number 1150 is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number 1150 has participated in 1 clinical trials.

Therapeutic areas: Breast Cancer, Breast Neoplasms.

Sponsors: Sanofi.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 1150?

Investigational Site Number 1150 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 1150 conducted?

Investigational Site Number 1150 has 1 clinical trials on record. Their work covers Breast Cancer, Breast Neoplasms.

Is Investigational Site Number 1150 accredited by Crixeo Health?

Investigational Site Number 1150 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 1150?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.